MIST
MilestoneยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MIST Profile
Milestone Pharmaceuticals Inc.
A biopharmaceutical company that developing innovative cardiovascular medicines
1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, Quebec CA H4M 2X6
--
Milestone Pharmaceuticals Inc., was incorporated in 2003 under the laws of Quebec. The company is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular drugs. The company's lead product candidate, tripamide, is a new powerful calcium channel blocker that they designed as a fast-acting nasal spray for patients to self-administer. The company is developing tripamide for the treatment of specific arrhythmias, with the primary indication for the treatment of paroxysmal supraventricular tachycardia, or PSVT, followed by the treatment of atrial fibrillation with rapid ventricular rate, or AFIB-RVR.
